← Oncology Approval Tracker

FDA DECISION ·

Keytruda + chemoradiotherapy

pembrolizumab with chemoradiotherapy · Merck

FDA approvalNew or expanded indicationCervical cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Pembrolizumab with chemoradiotherapy for cervical cancer classified as FIGO 2014 stage III–IVA.

LAMPGEN ANALYSIS

Why it matters

The decision brought pembrolizumab into definitive therapy for a specified locally advanced group.

What research teams should watch

Use the stated FIGO edition, then align external beam radiation, brachytherapy, chemotherapy and immunotherapy schedules.

PRIMARY RECORDS

Sources